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3 Abstract T-type calcium channels are important modulators of both membrane potential and intracellular Ca 2+ concentrations, allowing them to play key roles in such diverse processes as aldosterone production from adrenal glomerulosa cells to boosting pain signals in nociceptors.
In both these examples, it is the Ca v 3.2 isoform that mediates Ca 2+ influx. This isoform is also of particular interest because mutations in its gene (CACNA1H) that enhance channel activity have been associated with idiopathic generalized epilepsies, while mutations that disrupt its activity have been associated with autism spectrum disorders. Block of T-channel activity has been proposed to contribute to the therapeutic usefulness of a wide variety of drugs, such as antihypertensives, antipsychotics, and antidepressants. Recent evidence strongly supports the hypothesis that block of Ca v 3.2 channels might be useful in the treatment of neuropathic pain.
Therefore, it is of particular interest that Ca v 3.2 channels are exquisitely regulated by G protein coupled receptors and various downstream effectors. This Perspective summarizes recent findings on this regulation and the novel pathways specifically activated by either neurokinin I, corticotropin-releasing factor receptor 1 (CRF-1), or dopamine D 1 receptors.
This article has not been copyedited and formatted. The final version may differ from this version. Seminal studies on the mechanism of action of antihypertensive agents identified voltage-gated Ca 2+ channels as key players in smooth muscle contraction (Godfraind et al., 1986 (McGivern, 2006) . Therefore, inhibition by G-protein coupled receptors (GPCR) provides another therapeutic strategy; much like N-type channel inhibition contributes to morphine analgesia. Early studies of hormonal regulation of native T-currents led to conflicting results, with some groups reporting stimulation, others inhibition, and others no effect. Studies on recombinant channels have partially resolved this conundrum, revealing that regulation is isoform specific and pathway dependent [reviewed in (Huc et al., 2009 ) and (Iftinca and Zamponi, 2009) ]. The most highly regulated T-channel isoform to date is Ca v 3.2. In contrast to its brothers, Ca v 3.1 and 3.3, it can be regulated by GPCRs via direct action of G protein β 2 γ 2 subunits (DePuy et al., 2006; Wolfe et al., 2003) , or via unknown mechanisms that do not involve βγ subunits or canonical protein kinase pathways [ (Tao et al., 2008) ; Fig. 1 ].
In this issue of Molecular Pharmacology, Meza and coworkers describe a new mechanism whereby GPCRs can modulate Ca v 3.2 channels (Rangel et al., in press ). These authors report that activation of neurokinin 1 (NK1) receptors leads to reversible inhibition of recombinant human Ca V 3.2 channels transiently expressed in human embryonic kidney cells . This finding is of general interest because Ca V 3.2 and NK1 receptors, which are activated by the tachykinin peptides substance P and neurokinin A, are both expressed in dorsal This article has not been copyedited and formatted. The final version may differ from this version. protein-coupled receptor) expressed in the adrenocarcinomal cell line H295R was mediated by direct interaction of G 2  2 subunits with the α subunit of Ca v 3.2 (Wolfe et al., 2003) . It is important to note that this form of regulation was specific to the G2 subunit. Thus, a possible explanation for the observed differences in the signaling by these two G q/11 protein-coupled receptors could be attributed to the low endogenous level of G 2  2 dimer expression in HEK-293 cells. Recent studies from the Barrett lab indicate that Ca v 3.2 must be phosphorylated by protein kinase A to be responsive to G 2  2 inhibition (Hu et al., 2009 ). This leads to the scenario where differences in basal phosphorylation states can alter hormone-mediated inhibition of Ca v 3.2, and adds yet another possible explanation for the variability observed in its regulation.
The results of Rangel et al., also differ from those reported by Tao et al., who reported that corticotropin-releasing factor receptor 1 (CRF-1) also specifically inhibits recombinant Ca v 3.2 channels in HEK-293 cells by a pathway that involves neither G nor protein kinase C (Tao et al., 2008) . In their study, CRF-1 mediated inhibition was not affected by coexpression with RGS2, and was not affected by blockers of PLC, tyrosine kinases, Ca (Kammermeier et al., 2000) ] is able to outcompete the channel and block inhibition.
These studies highlight the complexity of Ca v 3.2 regulation, which partially accounts for the disparate findings of native T-current regulation and more recently with recombinant channels. In addition to differences in experimental conditions, these findings suggest that the choice of GPCR activated may also determine the form of regulation observed. Therefore, it will be of great interest when these findings on recombinant channels can be confirmed in native cells where the appropriate combination of GPCR, G protein subunits, and Ca v 3.2 isoform are expressed. It will also be important to test the effect of Ca v 3.2 splice variation on regulation (Zhong et al., 2006) , as mutations that alter Ca v 3.2 splicing contribute to the absence epilepsy phenotypes (Powell et al., 2009 ).
This article has not been copyedited and formatted. The final version may differ from this version. , 2006; Hu et al., 2009; Wolfe et al., 2003) . Inhibition is due to a reduction in the probability of channel opening with no effect on the voltage-dependence of either activation or inactivation. Mutation of serine 1107 to alanine disrupts the ability of G 2  2 mediated inhibition. This pathway may account for the regulation of T-currents observed in adrenal glomerulosa cells (Drolet et al., 1997) . B, Pathway described by the Soong lab, which indicates CRF-1 receptors act via G s to inhibit channel activity by a pathway that does not involve any protein kinase (Tao et al., 2008) . Inhibition results in a shift in the voltage dependence of inactivation. C, Pathway described by the Meza lab, which
indicates that neurokinin-1 receptors inhibit channel activity via a pathway that is independent of G, but requires PKC (Rangel et al., in press ). Inhibition occurs with no change in the voltage dependence of channel gating. This pathway may account for the PKC regulation of T-currents observed in DRG neurons (Schroeder et al., 1990 ).
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